Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Avanos Medical (AVNS)
NYSE:AVNS
Holding AVNS?
Track your performance easily
AVNS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$16.02 - $25.36
Previous Close$16.08
Volume1.24M
Average Volume (3M)282.18K
Market Cap
$738.99M
Enterprise Value$852.19M
Total Cash (Recent Filing)$89.00M
Total Debt (Recent Filing)$202.20M
Price to Earnings (P/E)47.7
Beta1.49
Next Earnings
Feb 25, 2025EPS Estimate
$0.4Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.34
Shares Outstanding45,956,997
10 Day Avg. Volume5,232,115
30 Day Avg. Volume282,183
Standard Deviation0.10
R-Squared0.23
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.60
Price to Sales (P/S)1.08
Price to Cash Flow (P/CF)8.00
P/FCF Ratio9.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.31
Enterprise Value/Gross Profit2.24
Enterprise Value/Ebitda10.46
Forecast
1Y Price Target
$20.00Price Target Upside24.38% Upside
Rating ConsensusHold
Number of Analyst Covering2
Avanos Medical News
PremiumCompany Announcements
Avanos Medical Appoints Interim CFO Warren Machan
PremiumCompany Announcements
Avanos Medical Reports Q3 Results and CEO Retirement
PremiumCompany Announcements
Avanos Medical Announces CEO Retirement and Interim Appointment
Bulls Say, Bears Say
Bulls Say
Business GrowthDigestive Health grew nearly 6% organically, supported by continued double-digit growth in NeoMed.
Financial PerformanceAdjusted EPS was slightly ahead of consensus, driven by management's cost savings improvement efforts.
LeadershipThe appointment of interim CEO Michael Greiner is seen as a positive step in the company's transformation process.
Bears Say
Financial GuidanceThe company lowered its full-year 2024 guidance expectation, with revenue and adjusted EPS forecasted to be lower.
Product PerformancePain Management and Surgical Pain segments were particularly weighed down by the ON-Q product line.
Sales PerformanceTotal sales were light of Street expectations due to disruption within its On-Q and COOLIEF businesses.
---
Ownership Overview
2.27% Insiders
30.82% Mutual Funds
26.46% Other Institutional Investors
11.94% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AVNS FAQ
What was Avanos Medical’s price range in the past 12 months?
Avanos Medical lowest stock price was $16.02 and its highest was $25.36 in the past 12 months.
What is Avanos Medical’s market cap?
Currently, no data Available
When is Avanos Medical’s upcoming earnings report date?
Avanos Medical’s upcoming earnings report date is Feb 25, 2025 which is in 65 days.
How were Avanos Medical’s earnings last quarter?
Avanos Medical released its earnings results on Oct 30, 2024. The company reported $0.33 earnings per share for the quarter, missing the consensus estimate of $0.353 by -$0.023.
Is Avanos Medical overvalued?
According to Wall Street analysts Avanos Medical’s price is currently Undervalued.
Does Avanos Medical pay dividends?
Avanos Medical does not currently pay dividends.
What is Avanos Medical’s EPS estimate?
Avanos Medical’s EPS estimate is $0.4.
How many shares outstanding does Avanos Medical have?
Avanos Medical has 45,956,997 shares outstanding.
What happened to Avanos Medical’s price movement after its last earnings report?
Avanos Medical reported an EPS of $0.33 in its last earnings report, missing expectations of $0.353. Following the earnings report the stock price went down -17.897%.
Which hedge fund is a major shareholder of Avanos Medical?
Among the largest hedge funds holding Avanos Medical’s share is Gotham Asset Management LLC. It holds Avanos Medical’s shares valued at 644K.
---
Avanos Medical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$20.00 (24.38% Upside)
$20.00 (24.38% Upside)
Blogger Sentiment
Bullish
AVNS Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 42.5K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-27.43%
12-Months-Change
Fundamentals
Return on Equity
1.77%
Trailing 12-Months
Asset Growth
-3.98%
Trailing 12-Months
Company Description
Avanos Medical
Avanos Medical, Inc. is a medical technology company, which focuses on delivering clinically medical device solutions to improve patients' quality of life. Its portfolio of innovative product offerings focused on respiratory and digestive health, along with surgical and interventional pain management to improve patient outcomes and reduce the cost of care. Its brands include ON-Q, Coolife, Microcuff, MIC-Key, Quilbloc and Home pump. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.
---
AVNS Company Deck
---
AVNS Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture. While there were notable achievements in the Digestive Health and Game Ready portfolios, as well as progress in transformation efforts and SG&A optimization, there were significant challenges in the surgical pain portfolio and COOLIEF offering in North America. The HA portfolio also faced pricing pressures.Read More>---
AVNS Stock 12 Month Forecast
Average Price Target
$20.00
▲(24.38% Upside)
Technical Analysis
Best Analysts Covering AVNS
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-16.80%
reiterated a buy rating 7 months ago
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -16.80% per trade.
---